We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Pegfilgrastim is safe and significantly reduces the incidence of FN in breast cancer patients.
No takes yet. Share an insight, caveat, or question.
Kosaka et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: